S
Stepy Thomas
Researcher at Emory University
Publications - 13
Citations - 468
Stepy Thomas is an academic researcher from Emory University. The author has contributed to research in topics: Population & Internal medicine. The author has an hindex of 7, co-authored 10 publications receiving 314 citations. Previous affiliations of Stepy Thomas include Colorado Department of Public Health and Environment.
Papers
More filters
Journal ArticleDOI
Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States
Ben J. Metcalf,Sopio Chochua,Robert E. Gertz,Zhongya Li,Hollis Walker,T. Tran,Paulina A. Hawkins,Anita Glennen,Ruth Lynfield,Y. Li,Lesley McGee,Bernard Beall,Art Reingold,S. Brooks,H. Randel,Lisa Miller,B. White,Deborah Aragon,Meghan Barnes,J. Sadlowski,Sue Petit,Matthew L. Cartter,C. Marquez,M. Wilson,Monica M. Farley,Stepy Thomas,Amy Tunali,W. Baughman,Lee H. Harrison,J. Benton,T. Carter,Rosemary Hollick,K. Holmes,A. Riner,Corinne Holtzman,Richard Danila,K. MacInnes,Karen Scherzinger,Kathy Angeles,Joseph Bareta,L. Butler,S. Khanlian,R. Mansmann,Megin Nichols,Nancy M. Bennett,S. Zansky,S. Currenti,Suzanne McGuire,Ann Thomas,M. Schmidt,Jamie Thompson,Tasha Poissant,William Schaffner,Brenda Barnes,K. Leib,K. Dyer,L. McKnight,R. Gierke,Olivia Almendares,J. Hudson,L. McGlone,Gayle Fischer Langley +61 more
TL;DR: WGS-based antimicrobial phenotype prediction was an informative alternative to BDT for invasive pneumococci and correctly predicted penicillin-binding protein types and common resistance determinants.
Journal ArticleDOI
Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA
Benjamin J. Metcalf,Sopio Chochua,Robert E. Gertz,Paulina A. Hawkins,Jessica N. Ricaldi,Zhongya Li,Hollis Walker,T. Tran,J. Rivers,S. Mathis,Delois Jackson,Anita Glennen,Ruth Lynfield,Lesley McGee,Bernard Beall,Art Reingold,S. Brooks,H. Randel,Lisa Miller,B. White,Deborah Aragon,Meghan Barnes,J. Sadlowski,Sue Petit,Matthew L. Cartter,C. Marquez,M. Wilson,Monica M. Farley,Stepy Thomas,Amy Tunali,W. Baughman,Lee H. Harrison,J. Benton,T. Carter,Rosemary Hollick,K. Holmes,A. Riner,Corinne Holtzman,Richard Danila,K. MacInnes,Karen Scherzinger,Kathy Angeles,Joseph Bareta,L. Butler,S. Khanlian,R. Mansmann,Megin Nichols,Nancy M. Bennett,S. Zansky,S. Currenti,Suzanne McGuire,Ann Thomas,M. Schmidt,Jamie Thompson,Tasha Poissant,William Schaffner,Brenda Barnes,K. Leib,K. Dyer,L. McKnight,Olivia Almendares,J. Hudson,L. McGlone,Cynthia G. Whitney,Stephanie J. Schrag,Gayle Fischer Langley +65 more
TL;DR: The WGS-based assignment of iGBS resistance features and serotypes is an accurate substitute for phenotypic testing.
Journal ArticleDOI
Burden of Candidemia in the United States, 2017
Sharon Tsay,Yi Mu,Sabrina R Williams,Erin Epson,Joelle Nadle,Wendy Bamberg,Devra Barter,Helen Johnston,Monica M. Farley,Monica M. Farley,Sasha Harb,Stepy Thomas,Lindsay Bonner,Lee H. Harrison,Rosemary Hollick,Kaytlynn Marceaux,Rajal K. Mody,Brittany Pattee,Sarah Shrum Davis,Erin C Phipps,Brenda L Tesini,Anita Gellert,Alexia Y Zhang,William Schaffner,Sherry Hillis,Danielle Ndi,Caroline R Graber,Brendan R Jackson,Tom Chiller,Shelley S. Magill,Snigdha Vallabhaneni +30 more
TL;DR: This analysis highlights the substantial burden of candidemia in the U.S. because candidemia is only one form of invasive candidiasis, the true burden of invasive infections due to Candida is higher.
Journal ArticleDOI
Severe Diarrhea Caused by Cholera Toxin–Producing Vibrio cholerae Serogroup O75 Infections Acquired in the Southeastern United States
Melissa Tobin-D'Angelo,Allison R Smith,Sandra N. Bulens,Stepy Thomas,Mary Hodel,Hidemasa Izumiya,Eiji Arakawa,Masatomo Morita,Haruo Watanabe,Constance Marin,Michele B. Parsons,K. D. Greene,Kara Cooper,Danielle Haydel,Cheryl A. Bopp,Patricia A. Yu,Eric D. Mintz +16 more
TL;DR: The occurrence of these cases over many years and the concurrent identification of V. cholerae O75 in water from a Gulf Coast state suggest that these strains may survive for long periods in this environment.
Journal ArticleDOI
Early-onset group B streptococcal disease in the United States: potential for further reduction.
Jennifer R. Verani,Nancy L Spina,Ruth Lynfield,William Schaffner,Lee H. Harrison,Amy Holst,Stepy Thomas,Jessica M Garcia,Karen Scherzinger,Deborah Aragon,Susan Petit,Jamie Thompson,Lauren Pasutti,Roberta B. Carey,Lesley McGee,Emily J. Weston,Stephanie J. Schrag +16 more
TL;DR: It is estimated that under optimal implementation, cases of early-onset GBS disease could be reduced by 26–59% with the largest benefit from a single intervention coming from improved use of intrapartum prophylaxis (16% decrease).